{"id":"W4241968959","doi":"10.1016/j.jval.2014.08.2267","title":"Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Ofatumumab; Chlorambucil; Medicine; Fludarabine; Population; Time horizon; Quality-adjusted life year; Cost effectiveness; Chronic lymphocytic leukemia; Internal medicine; Oncology; Leukemia; Chemotherapy; Mathematics; Risk analysis (engineering); Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003385083,0.0002785963,0.001160123,0.000536403,0.00004012477,0.000008166605,0.0002949415,0.0001656791,0.00004519822],"category_scores_gemma":[0.001048308,0.0002736502,0.0000644721,0.00131289,0.0001189327,0.00007492243,0.0001277214,0.0006020861,0.00001544992],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.7144316,"about_ca_system_score_gemma":0.4239025,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9961388,"about_ca_topic_score_gemma":0.968356,"domain_scores_codex":[0.9955929,0.0007368666,0.001130881,0.0005874826,0.0008314223,0.001120444],"domain_scores_gemma":[0.9968898,0.001737392,0.0002040129,0.0007304607,0.00009250025,0.0003458477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001787736,0.00008888933,0.0158068,0.0131018,0.00002380674,0.0003932894,0.0006792978,0.9588198,0.00008241482,0.0004452943,0.0001310582,0.008639825],"study_design_scores_gemma":[0.05312751,0.0006807284,0.03833037,0.00570795,0.000006676354,0.00009550681,0.0001063842,0.8994803,0.0009842692,0.0001470737,0.001108109,0.0002251655],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942989,0.002242197,0.00009592556,0.0002719132,0.0002670524,0.002302485,0.00001325213,0.00002169747,0.000486589],"genre_scores_gemma":[0.9984756,0.0008024241,0.00007142944,0.0002133211,0.0001108706,0.0001842613,0.00003234913,0.00005162333,0.00005814631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2905292,"threshold_uncertainty_score":0.9999716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05877112671093143,"score_gpt":0.329355149885676,"score_spread":0.2705840231747446,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}